{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T02:40:17Z","timestamp":1794883217598,"version":"4.9.1"},"reference-count":27,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Healthgen Biotech. Inc.","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2025,6,6]]},"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite inadequate supply and potential contamination risk, human plasma has remained the only source for human serum albumin (pHSA) intravenous administration since the 1940s.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      We sought to establish the safety and efficacy of OsrHSA, a recombinant HSA from bioengineered\n                      <jats:italic>Oryza sativa<\/jats:italic>\n                      (rice).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>In this multicentre, randomised, double-blind and positive-controlled study, patients with decompensated liver cirrhosis and serum albumin \u226430\u2009g\/L were recruited from 22 centres in China. The patients were randomly assigned to OsrHSA or pHSA (4:1) to once-daily intravenous injection (10\u2009g or 20\u2009g) until their serum albumin level reached 35\u2009g\/L, for a maximum of 2 weeks, with 2 weeks of follow-up. The primary outcome was the proportion of patients to reach a serum albumin level of 35\u2009g\/L (non-inferiority margin &lt;\u22120.20). Outcomes were evaluated in patients who received the study drug and had at least one post-baseline serum albumin value (full analysis set, FAS). Safety was evaluated in all patients who received the study drug.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Between 22 March 2021 and 2 June 2022, 220 patients received OsrHSA (n=175) or pHSA (n=45). 216 patients were included in the FAS (OsrHSA, n=171; pHSA, n=45). Primary outcome of OsrHSA (130\/171, 76%) was non-inferior to pHSA (34\/45, 75.6%) (difference=0.5%; lower limit of 97.5%\u2009CI=\u22120.119). There was no significant difference between all secondary outcomes of OsrHSA and pHSA. There were no drug-related serious adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Rice-derived HSA is non-inferior to plasma-derived HSA in efficacy and safety. This finding should be confirmed in phase 3 trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04835480\">NCT04835480<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2025-335577","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T13:20:24Z","timestamp":1750771224000},"page":"1476-1485","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":15,"title":["Rice-derived recombinant human serum albumin as an alternative to human plasma for patients with decompensated liver cirrhosis: a randomised, double-blind, positive-controlled and non-inferiority trial"],"prefix":"10.1136","volume":"74","clinical-trial-number":[{"clinical-trial-number":"nct04835480","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04384523","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04835480","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct06355479","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Junqi","family":"Niu","sequence":"first","affiliation":[{"name":"Department of Hepatology, Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Changchun, Jilin, China"},{"name":"China-Singapore Belt and Road Joint Laboratory on Liver Disease Research, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhang","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Changchun, Jilin, China"},{"name":"China-Singapore Belt and Road Joint Laboratory on Liver Disease Research, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiqiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Center for Liver Diseases, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Qin","sequence":"additional","affiliation":[{"name":"Healthgen Biotech, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuisong","family":"Wu","sequence":"additional","affiliation":[{"name":"The Third People\u2019s Hospital of Zhenjiang, Zhenjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zujiang","family":"Yu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichun","family":"Wang","sequence":"additional","affiliation":[{"name":"West China Hospital of Sichuan University, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjie","family":"Hu","sequence":"additional","affiliation":[{"name":"Liver Disease Center, Beijing You\u2019an Hospital Affiliated to Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Li","sequence":"additional","affiliation":[{"name":"PingXiang people\u2019s Hospital, JiangXi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shandong Public Health Clinical Center, Changchun, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[{"name":"Taihe Hospital, Shiyan, Shiyan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lvfeng","family":"Yao","sequence":"additional","affiliation":[{"name":"Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Ming","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatology, The Affiliated Infectious Disease Hospital of Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6261-0953","authenticated-orcid":false,"given":"Yida","family":"Yang","sequence":"additional","affiliation":[{"name":"First Affiliated Hospital of Zhejiang University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Lu","sequence":"additional","affiliation":[{"name":"First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Gu","sequence":"additional","affiliation":[{"name":"The Sixth People\u2019s Hospital of Shenyang, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Wu","sequence":"additional","affiliation":[{"name":"The Sixth People\u2019s Hospital of Shenyang, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Mao","sequence":"additional","affiliation":[{"name":"Lanzhou University First Affiliated Hospital, Lanzhou, Gansu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Wuhan University People\u2019s Hospital, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Shang","sequence":"additional","affiliation":[{"name":"Henan Provincial People\u2019s Hospital, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingliang","family":"Lin","sequence":"additional","affiliation":[{"name":"The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Dong","family":"Jia","sequence":"additional","affiliation":[{"name":"Liver Research Center, Beijing Friendship Hospital, Capital Medial University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengmei","family":"Wang","sequence":"additional","affiliation":[{"name":"Tianjin Third Center Hospital, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5820-950X","authenticated-orcid":false,"given":"Jiming","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Huashan Hospital Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Ma","sequence":"additional","affiliation":[{"name":"Healthgen Biotech, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Changchun, Jilin, China"},{"name":"China-Singapore Belt and Road Joint Laboratory on Liver Disease Research, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cliff Y","family":"Yang","sequence":"additional","affiliation":[{"name":"Healthgen Biotech, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7488-6356","authenticated-orcid":false,"given":"Daichang","family":"Yang","sequence":"additional","affiliation":[{"name":"Healthgen Biotech, Wuhan, China"},{"name":"Wuhan University, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"2026073008001273000_74.9.1476.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1979.03290490033021"},{"key":"2026073008001273000_74.9.1476.2","first-page":"s18","article-title":"Clinical use of albumin","volume":"11 Suppl 4","author":"Caraceni","year":"2013","journal-title":"Blood Transfus"},{"key":"2026073008001273000_74.9.1476.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2011.12.002"},{"key":"2026073008001273000_74.9.1476.4","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1996.tb03024.x"},{"key":"2026073008001273000_74.9.1476.5","unstructured":"Blood safety and availability. 2024. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/blood-safety-and-availability"},{"key":"2026073008001273000_74.9.1476.6","unstructured":"Guidance on increasing supplies of plasma-derived medicinal products in low- and middle-income countries through fractionation of domestic plasma. 2024. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240021815"},{"key":"2026073008001273000_74.9.1476.7","unstructured":"Protecting the blood supply during infectious disease outbreaks: guidance for national blood services. 2024. Available: https:\/\/www.who.int\/publications\/i\/item\/9789241515214"},{"key":"2026073008001273000_74.9.1476.8","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0000000000000535"},{"key":"2026073008001273000_74.9.1476.9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1467-7652.2003.00008.x"},{"key":"2026073008001273000_74.9.1476.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2005.08.021"},{"key":"2026073008001273000_74.9.1476.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2013.04.037"},{"key":"2026073008001273000_74.9.1476.12","doi-asserted-by":"publisher","DOI":"10.1177\/0091270004269646"},{"key":"2026073008001273000_74.9.1476.13","unstructured":"Notice regarding administrative action related to violation of pharmaceutical affairs law. Mitsubishi Tanabe Pharma. 2010. Available: www.mt-pharma.co.jp\/e\/news\/assets\/pdf\/e100413_med.pdf"},{"key":"2026073008001273000_74.9.1476.14","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-arplant-050213-035850"},{"key":"2026073008001273000_74.9.1476.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2022.04.002"},{"key":"2026073008001273000_74.9.1476.16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1109736108"},{"key":"2026073008001273000_74.9.1476.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2019.10.005"},{"key":"2026073008001273000_74.9.1476.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2013.04.036"},{"key":"2026073008001273000_74.9.1476.19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112464"},{"key":"2026073008001273000_74.9.1476.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.024"},{"key":"2026073008001273000_74.9.1476.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2013.05.015"},{"key":"2026073008001273000_74.9.1476.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.07.055"},{"key":"2026073008001273000_74.9.1476.23","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.03.021"},{"key":"2026073008001273000_74.9.1476.24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908053410603"},{"key":"2026073008001273000_74.9.1476.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022166"},{"key":"2026073008001273000_74.9.1476.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.07.020"},{"key":"2026073008001273000_74.9.1476.27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2023.08.006","article-title":"A Study of Impact of Fixed-Dose Albumin Infusion on Outcome in Patients With Cirrhosis and Infection: A Randomized Open-label Clinical Trial","volume":"14","author":"Devisetty","year":"2024","journal-title":"J Clin Exp Hepatol"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2025-335577","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:38:10Z","timestamp":1785436690000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2025-335577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":27,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,8,7]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/gutjnl-2025-335577"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2025-335577","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]}}}